NMN Capsules contain nicotinamide mononucleotide, a nucleotide derivative associated with the nicotinamide adenine dinucleotide (NAD+) biosynthetic pathway. The encapsulated format provides a standardized research material for controlled laboratory analysis involving nucleotide chemistry, precursor conversion, and NAD+-associated biochemical mechanisms.
For laboratory research use only. Not for human or animal consumption. The capsule format is intended solely for research-material containment and does not indicate suitability for oral administration, supplementation, or clinical use.
Nordsci provides independent analytical testing and lot-specific documentation for product identity and quality verification. Researchers should consult the applicable Certificate of Analysis before beginning experimental work.
NMN Capsules contain nicotinamide mononucleotide, a nucleotide derivative associated with the biosynthesis of nicotinamide adenine dinucleotide (NAD+). This encapsulated material is supplied for controlled laboratory research involving nucleotide chemistry, precursor conversion, enzyme-mediated reactions, and NAD+-associated biochemical pathways.
The capsule format provides standardized containment for laboratory material handling and experimental documentation. It does not indicate suitability for ingestion, supplementation, oral delivery, clinical use, or administration to humans or animals.
For laboratory research use only. Not for human or animal consumption.
NMN Capsules – Research Specifications:
| Product Name | NMN Capsules |
| Chemical Name | Nicotinamide Mononucleotide |
| Common Abbreviation | NMN |
| Molecular Formula | C11H15N2O8P |
| Molecular Weight | Approximately 334.22 g/mol |
| CAS Number | 1094-61-7; verify against the lot-specific Certificate of Analysis |
| Compound Type | Nucleotide derivative |
| Format | Encapsulated laboratory research material |
| Purity / Identity | Refer to the lot-specific Certificate of Analysis for reported analytical verification |
| Analytical Testing | Independent analytical documentation is available; consult the applicable COA for reported methods and results |
| Appearance | Capsule format |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, direct light, and moisture |
| Research Use Only | Not for human or animal consumption, administration, supplementation, clinical use, or in-vivo procedures |
Nicotinamide mononucleotide is a phosphorylated nucleotide derivative associated with the NAD+ biosynthetic pathway. In biochemical research, NMN may be examined as an intermediate involved in enzyme-mediated nucleotide conversion and the formation of nicotinamide adenine dinucleotide.
NAD+ participates in redox reactions and serves as a substrate or cofactor in multiple enzymatic systems. Controlled laboratory investigations involving NMN may evaluate its chemical identity, stability, conversion behavior, pathway kinetics, and interaction with NAD+-associated enzymes.
Research observations must remain limited to the specific experimental model, analytical method, and laboratory conditions used. References to NAD+-associated pathways do not establish a physiological benefit, clinical application, expected outcome, or suitability for human or animal use.
Researchers examining related biochemical pathways may also review laboratory materials such as NAD+, MOTS-C, and Epithalon. Each compound must be evaluated independently according to its identity, analytical documentation, and intended research protocol.
Important Research Notice: Nordsci research materials are supported by lot-specific analytical documentation. Researchers should review the corresponding Certificate of Analysis before beginning experimental work.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR LABORATORY RESEARCH USE. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR IN-VIVO, DIAGNOSTIC, THERAPEUTIC, FOOD, DRUG, COSMETIC, VETERINARY, OR DIETARY-SUPPLEMENT USE.
NMN may be examined in controlled laboratory models involving the NAD+ biosynthetic pathway. Research may evaluate precursor conversion, pathway kinetics, enzyme activity, and the detection or quantification of related molecular intermediates.
In-vitro research may include NMN as an experimental variable when examining NAD+-associated reactions within isolated biochemical, cellular, or enzymatic systems. Appropriate controls are required to distinguish compound-associated observations from other experimental variables.
NMN may be incorporated into laboratory models designed to characterize molecular pathways in which NAD+ availability is an experimental parameter. Findings from these models must not be interpreted as evidence of an anti-aging effect, therapeutic application, or consumer benefit.
Qualified laboratories may investigate NMN within controlled systems involving nucleotide conversion, redox chemistry, and NAD+-dependent molecular processes. Experimental conditions and acceptance criteria should be defined before testing begins.
NMN Capsules should be handled according to established laboratory procedures for research chemicals. Personnel should use appropriate personal protective equipment and prevent ingestion, inhalation, skin contact, cross-contamination, and unauthorized access.
The material should remain sealed until required for laboratory work. Storage conditions, lot identification, environmental parameters, and experimental variables should be documented to maintain traceability and facilitate reproducible research.
The capsule is a research-material containment format only. It is not an oral-delivery format and must not be administered to humans or animals.
Protocol Design Considerations: Laboratory protocols should document material identity, lot number, analytical method, environmental conditions, controls, sample-preparation procedures, and relevant instrument parameters. No dosing, administration, application, or in-vivo guidance is provided.
Note: This information is supplied solely for qualified laboratory reference. Experimental work must be performed by trained professionals in appropriately equipped research facilities.
Lot-specific Certificates of Analysis provide the available analytical information for NMN Capsules, including reported identity, quality parameters, testing methods, and results. Researchers should review the COA associated with the purchased lot rather than documentation from a different production batch.
Analytical documentation facilitates material verification, procurement review, traceability, and laboratory recordkeeping. A Certificate of Analysis does not establish safety, efficacy, clinical suitability, or authorization for human or animal use.
Laboratories sourcing NMN Capsules should prioritize analytical transparency, batch traceability, documented storage requirements, and compatibility with established research protocols. Nordsci supplies NMN Capsules exclusively as a laboratory research material accompanied by available lot-specific analytical documentation.
IMPORTANT: NMN Capsules are not approved or supplied for human consumption, animal consumption, clinical use, supplementation, compounding, diagnosis, treatment, prevention, or any other therapeutic application. No dosing, administration, or application instructions are provided. The purchaser is responsible for compliance with all applicable institutional and regulatory requirements.
